Inventor · disambiguated record
John Sidney
Also filed as: SIDNEY JOHN · SIDNEY JOHN C
18 granted patents·39 pending applications·857 citations·filing 1993–2022
96Inventor score
Top patents by PatentIndex Score
57 records- 0197US5736142AAlteration of immune response using pan DR-binding peptidesCYTEL CORP·Filed 1994·Granted Apr 7, 1998·300 cites·56 claims
- 0296US7026443B1Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2000·Granted Apr 11, 2006·92 cites·10 claims
- 0396US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0490US5750395ADNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptidesCYTEL CORP·Filed 1995·Granted May 12, 1998·73 cites·3 claims
- 0588US6413935B1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 1997·Granted Jul 2, 2002·73 cites·52 claims
- 0687US9340577B2HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2004·Granted May 17, 2016·21 cites·6 claims
- 0784US7202351B1Alteration of immune response using pan DR-binding peptidesPHARMEXA INC·Filed 2000·Granted Apr 10, 2007·20 cites·14 claims
- 0884US6689363B1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 1999·Granted Feb 10, 2004·69 cites·55 claims
- 0983US7572882B2Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2000·Granted Aug 11, 2009·6 cites·13 claims
- 1079US6413517B1Identification of broadly reactive DR restricted epitopesEPIMMUNE INC·Filed 1998·Granted Jul 2, 2002·40 cites·2 claims
- 1177US10703784B2Antigens and epitopes derived from Mycobacterium tuberculosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2012·Granted Jul 7, 2020·2 cites·6 claims
- 1276US6464980B1MAGE-1 c-terminal immunogenic peptidesEPIMMUNE INC·Filed 1996·Granted Oct 15, 2002·23 cites·5 claims
- 1372US7611713B2Inducing cellular immune responses to hepatitis B virus using peptide compositionsPHARMEXA INC·Filed 2003·Granted Nov 3, 2009·5 cites·5 claims
- 1471US8017745B2Plasmodium falciparum antigens and methods of useEPIMMUNE INC·Filed 2003·Granted Sep 13, 2011·3 cites·38 claims
- 1571US7252829B1HLA binding peptides and their usesIDM PHARMA INC·Filed 1998·Granted Aug 7, 2007·30 cites·3 claims
- 1666US2009012004A1HLA binding peptides and their usesIDM PHARMA INC·Filed 2007·Application pending·0 cites
- 1765US2009214632A1Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2008·Application pending·0 cites
- 1864US2008279924A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2007·Application pending·0 cites
- 1963US10059751B2Peptide combinations and uses thereof in treating dust mite allergyALK ABELLO AS·Filed 2014·Granted Aug 28, 2018·1 cites·15 claims
- 2061US2010099613A1Peptides for inducing a ctl and/or htl response to hepatitis c virusGENIMMUNE·Filed 2009·Application pending·0 cites
- 2160US2007098776A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2006·Application pending·0 cites
- 2259US2010068228A1Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid CompositionsPHARMEXA INC·Filed 2009·Application pending·0 cites
- 2358US2006093617A1Peptides for inducing a CTL and/or HTL response to hepatitis C virusEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 2457US2002160960A1HLA binding peptides and their usesFiled 2002·Application pending·0 cites
- 2555US2004157780A1CTL inducing peptides from c-erb2 (HER-2/neu)EPIMMUNE INC·Filed 2004·Application pending·0 cites
- 2654US2011318408A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2011·Application pending·0 cites
- 2754US2008260762A1HLA binding motifs and peptides and their usesGREY HOWARD M·Filed 2007·Application pending·0 cites
- 2854US2005049197A1Induction of immune response against desired determinantsEPIMMUNE INC·Filed 2004·Application pending·0 cites
- 2953US2020289629A1Toxoplasma gondii vaccines and their useMCLEOD RIMA·Filed 2020·Application pending·0 cites
- 3052US2006079453A1Hla binding peptides and their usesSIDNEY JOHN·Filed 2003·Application pending·0 cites
- 3151US2013017253A1Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid CompositionsSETTE ALESSANDRO·Filed 2012·Application pending·0 cites
- 3249US2005196403A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2005·Application pending·0 cites
- 3349US2003185822A1HLA-A2.1 binding peptides and their usesFiled 2002·Application pending·0 cites
- 3449US2005271676A1Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositionsEPIMMUNE INC·Filed 2005·Application pending·0 cites
- 3548US2012015401A1Plasmodium falciparum antigens and methods of useSETTE ALESSANDRO·Filed 2011·Application pending·0 cites
- 3648US2025231185A1Coronavirus T Cell Epitopes, Megapools and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 3748US2011097352A9Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 3848US2016193316A1Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid CompositionsEPIMMUNE INC·Filed 2015·Application pending·0 cites
- 3947US2002160019A1Identification of broadly reactive DR restricted epitopesFiled 2002·Application pending·0 cites
- 4046US2009304746A1Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2007·Application pending·0 cites
- 4145US2004053822A1Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4245US2004146519A1Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4344US2007059799A1Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositionsPHARMEXA INC·Filed 2006·Application pending·0 cites
- 4444US2007020327A1Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsFIKES JOHN·Filed 2006·Application pending·0 cites
- 4543US2023293630A1Coronavirus T Cell Epitopes and Uses ThereofLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 4643US2004048790A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 4743US2014147490A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2012·Application pending·0 cites
- 4842US2004157273A1Subunit vaccines with a2 supermotifsFiled 2002·Application pending·0 cites
- 4942US2004096445A1Subunit vaccines with A2 supermotifsFiled 2001·Application pending·0 cites
- 5042US2003224036A1Hla class I a2 tumor associated antigen peptides and vaccine compositionsFiled 2000·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Sidney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →